Tamoxifen – Lieferengpass: Eine Stellungnahme der Fachgesellschaft-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tamoxifen – Lieferengpass: Eine Stellungnahme der Fachgesellschaft

Published:2022-03 Issue:01 Volume:19 Page:26-29
ISSN:1611-6453
Container-title:Senologie - Zeitschrift für Mammadiagnostik und -therapie
language:de
Short-container-title:Senologie - Zeitschrift für Mammadiagnostik und -therapie

Author:

Publisher

Georg Thieme Verlag KG

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1768-6610.pdf

Reference16 articles.

1. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Early Breast Cancer Trialist's Collaborative Group;Lancet,2015

2. Hormonal therapy of breast cancer: new approaches and concepts;S S Legha;Ann Inten Med,1978

3. Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer;M Baum;Lancet,1983

4. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28896 women;Early Breast Cancer Trialist's Collaborative Group;N Engl J Med,1988

5. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5);F Cardoso;Ann Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3